Internal Medicine, Pulmonary Disease · Granbury, TX
NPI
1023190055
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3710 E US Highway 377 Ste 116
Granbury, TX, 76049
Phone (817) 579-3994
Groups this clinician bills Medicare through
Medicare paid, 2024
$216K
3,139 services
Medicare patients, 2024
1,043
Average age 75
Drug cost, 2024
$4.4M
7,489 prescriptions
Company payments, 2025
$10K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahmed S Bhatti was code 99214 (office e&m - established), 1,793 times for 898 patients. In total Ahmed S Bhatti billed 3,139 services in 29 codes, and Medicare paid $216K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,793 | 898 | $91.21 | $164K |
| 94726 Pulmonary Function Testing | Facility | 331 | 323 | $8.93 | $2,954 |
| 94729 Pulmonary Function Testing | Facility | 331 | 323 | $6.65 | $2,200 |
| 99213 Office E&M - Established | Office | 243 | 185 | $69.42 | $17K |
| 99204 Office E&M - New | Office | 219 | 219 | $118.25 | $26K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 54 | 11 | $0.22 | $11.94 |
| 96372 Injection Administration | Office | 25 | 21 | $10.15 | $254 |
| 36415 Venipuncture Blood Collection | Office | 25 | 22 | $8.65 | $216 |
| 31624 Bronchoscopy | Facility | 15 | 15 | $82.25 | $1,234 |
| 83880 Clinical Chemistry | Office | 15 | 15 | $36.19 | $543 |
| 99203 Office E&M - New | Office | 11 | 11 | $86.90 | $956 |
By year: 2022 $239K for 3,876 services; 2023 $237K for 3,495 services; 2024 $216K for 3,139 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 25 | 22 | $8.65 | $216 |
| 83880 Clinical Chemistry | 15 | 15 | $36.19 | $543 |
Medicare prescription drug claims, 2024
In 2024, the drug Ahmed S Bhatti prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 2,065 prescriptions and refills. In total Ahmed S Bhatti wrote 7,489 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 2,065 | 2,549 | 434 | $1.6M |
| Albuterol Sulfate Hfa Albuterol Sulfate | 843 | 952 | 429 | $21K |
| Prednisone Generic | 623 | 630 | 249 | $1,580 |
| Doxycycline Hyclate Generic | 529 | 529 | 241 | $3,683 |
| Spiriva Respimat Tiotropium Bromide | 446 | 528 | 99 | $267K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 240 | 300 | 66 | $31K |
| Breo Ellipta Fluticasone/Vilanterol | 231 | 282 | 45 | $108K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 186 | 218 | 52 | $137K |
| Azithromycin Generic | 184 | 230 | 63 | $1,443 |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 120 | 158 | 50 | $69K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 120 | 148 | 25 | $68K |
| Armodafinil Generic | 116 | 143 | 21 | $8,098 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 116 | 134 | 26 | $12K |
| Symbicort Budesonide/Formoterol Fumarate | 107 | 126 | 24 | $30K |
| Ipratropium Bromide Generic | 95 | 135 | 42 | $2,405 |
Brand drugs: 4,195 claims; generic drugs: 3,294 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ahmed S Bhatti $10K ($10K in general payments such as food, travel and fees) from 24 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $6,418.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 36 | $6,418 |
| GlaxoSmithKline, LLC. GSK | 31 | $531 |
| Jazz Pharmaceuticals Inc. JAZZ | 11 | $356 |
| Insmed, Inc. INSM | 16 | $320 |
| Verona Pharma, Inc. VRNA | 15 | $315 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 14 | $310 |
| Viatris Specialty LLC | 16 | $305 |
| Genzyme Corporation SNY | 12 | $262 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $197 |
| Actelion Pharmaceuticals US, Inc. JNJ | 4 | $178 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.